Driehaus Capital Management LLC Foghorn Therapeutics Inc. Transaction History

Driehaus Capital Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$5.05 - $8.0 $1.45 Million - $2.3 Million	288,088 Added 102.75%	568,470 $3.27 Million
Q1 2024 May 15, 2024	SELL	$2.82 - $7.94 $178,613 - $502,903	-63,338 Reduced 18.43%	280,382 $1.88 Million
Q1 2023 May 15, 2023	BUY	$4.66 - $8.99 $63,697 - $122,884	13,669 Added 4.14%	343,720 $2.13 Million
Q3 2022 Nov 14, 2022	SELL	$7.52 - $18.01 $397,725 - $952,530	-52,889 Reduced 13.81%	330,051 $2.83 Million
Q2 2022 Aug 15, 2022	BUY	$8.48 - $16.84 $533,731 - $1.06 Million	62,940 Added 19.67%	382,940 $5.21 Million
Q1 2022 May 16, 2022	BUY	$8.87 - $22.1 $2.04 Million - $5.08 Million	230,000 Added 255.56%	320,000 $4.87 Million
Q4 2021 Feb 14, 2022	BUY	$10.79 - $22.87 $971,099 - $2.06 Million	90,000 New	90,000 $2.06 Million

33.3M

8.7K

2.4K

Ticker FHTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,637,400
Market Cap $313M
Description
Foghorn Therapeutics Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines targeting genetically determined dependencies within the chromatin regulatory system. The company uses its proprietary Gene Traffic Control platform to identify, validate, and potentially drug targets within the system. It is developing FHD-28...

Get notified when there are updates to the investment portfolio of Driehaus Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Driehaus Capital Management LLC with notifications on news.